Literature DB >> 27701130

Classic Solitary Kaposi Sarcoma of the Foot in an Immunocompetent Patient: A Case Report.

Brian M Schmidt1, Crystal M Holmes1.   

Abstract

Kaposi sarcoma (KS) is a tumor derived from endothelial cell lineage caused by Kaposi sarcoma-associated virus or human herpesvirus-8. The authors have set forth to describe a unique presentation of the classical form of KS in a homosexual individual. The authors demonstrate that a full history and physical are important in determining how to guide treatment along with ancillary tests, which can prove vital to determine management strategy. The authors then provide a brief discussion about variants of KS, biopsy techniques, and current treatment options available to patients diagnosed with this condition. The patient described is a 60-year-old male of Eastern European descent, who is immunocompetent in a monogamous homosexual relationship with a new onset and rapidly progressing skin lesion on the plantar aspect of his foot. Surgical excision of the tumor was performed and surveillance was determined to be the treatment of choice.

Entities:  

Mesh:

Year:  2016        PMID: 27701130

Source DB:  PubMed          Journal:  Wounds        ISSN: 1044-7946            Impact factor:   1.546


  3 in total

1.  Kaposi Sarcoma in an Human Immunodeficiency Virus (HIV)-Seronegative Mediterranean Female: Report of a Rare Case.

Authors:  Marios Grigoriou; Konstantinia E Kofina; Aristeidis Ioannidis; Domniki K Gerasimidou; Christoforos Efthymiadis; Thomas Zaramboukas
Journal:  Am J Case Rep       Date:  2017-07-26

2.  Nonepidemic Kaposi sarcoma: A recently proposed category.

Authors:  Tiffany Hinojosa; Daniel J Lewis; Melinda Liu; Gustavo Garza; Ramya Vangipuram; Elmira Ramos; Julio César Salas-Alanis; Zeena Y Nawas; Stephen K Tyring
Journal:  JAAD Case Rep       Date:  2017-09-03

3.  A case of mistaken identity: classic Kaposi sarcoma misdiagnosed as a diabetic foot ulcer in an atypical patient.

Authors:  Garneisha M Torrence; James S Wrobel
Journal:  Clin Diabetes Endocrinol       Date:  2019-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.